Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) EBIT Margin (2020 - 2025)

RxSight (RXST) has disclosed EBIT Margin for 6 consecutive years, with 87.98% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBIT Margin rose 3210.0% year-over-year to 87.98%, compared with a TTM value of 6.07% through Dec 2025, down 196.0%, and an annual FY2025 reading of 6.07%, down 196.0% over the prior year.
  • EBIT Margin was 87.98% for Q4 2025 at RxSight, up from 40.14% in the prior quarter.
  • Across five years, EBIT Margin topped out at 87.98% in Q4 2025 and bottomed at 319.6% in Q1 2021.
  • Average EBIT Margin over 5 years is 91.73%, with a median of 60.92% recorded in 2023.
  • The sharpest move saw EBIT Margin crashed -184109bps in 2021, then skyrocketed 14435bps in 2022.
  • Year by year, EBIT Margin stood at 174.02% in 2021, then soared by 46bps to 93.18% in 2022, then soared by 59bps to 38.02% in 2023, then surged by 247bps to 55.89% in 2024, then surged by 57bps to 87.98% in 2025.
  • Business Quant data shows EBIT Margin for RXST at 87.98% in Q4 2025, 40.14% in Q3 2025, and 41.63% in Q2 2025.